Report Detail

Pharma & Healthcare Global Preclinical CRO Treatment Market Professional Survey Report 2019

  • RnM3792030
  • |
  • 30 September, 2019
  • |
  • Global
  • |
  • 106 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

A preclinical CRO treatment is likely to offer the knowledge, experience, and skill needed to take a pharmaceutical medical device or product from the drawing board to distribution. The preclinical contract research organizations (CRO) sector has witnessed a period of tremendous development in the past, profiting from quickly growing (R&D) spending. Several pharmaceutical companies have lost revenue owing to growing patent expirations thus encouraging several manufacturers to outsource factors of the drug manufacturing method to CROs to decrease costs. Due to this, CROs are witnessing significant development.

The global Preclinical CRO Treatment market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Preclinical CRO Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Preclinical CRO Treatment market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Preclinical CRO Treatment in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Preclinical CRO Treatment manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Charles River Laboratories
Laboratory Corporation of America
Envigo
Eurofins Scientific
PRA Health Science
Wuxi AppTec
Medpace
Pharmaceutical Product Development
Paraxel

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Bioanalysis and DMPK Studies
Toxicology Testing
Others

Segment by Application
Biopharmaceutical Companies
Government and Academic Institutes
Medical Device Companies


Table of Contents

    Executive Summary

      1 Industry Overview of Preclinical CRO Treatment

      • 1.1 Definition of Preclinical CRO Treatment
      • 1.2 Preclinical CRO Treatment Segment by Type
        • 1.2.1 Global Preclinical CRO Treatment Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Bioanalysis and DMPK Studies
        • 1.2.3 Toxicology Testing
        • 1.2.4 Others
      • 1.3 Preclinical CRO Treatment Segment by Applications
        • 1.3.1 Global Preclinical CRO Treatment Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Biopharmaceutical Companies
        • 1.3.3 Government and Academic Institutes
        • 1.3.4 Medical Device Companies
      • 1.4 Global Preclinical CRO Treatment Overall Market
        • 1.4.1 Global Preclinical CRO Treatment Revenue (2014-2025)
        • 1.4.2 Global Preclinical CRO Treatment Production (2014-2025)
        • 1.4.3 North America Preclinical CRO Treatment Status and Prospect (2014-2025)
        • 1.4.4 Europe Preclinical CRO Treatment Status and Prospect (2014-2025)
        • 1.4.5 China Preclinical CRO Treatment Status and Prospect (2014-2025)
        • 1.4.6 Japan Preclinical CRO Treatment Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Preclinical CRO Treatment Status and Prospect (2014-2025)
        • 1.4.8 India Preclinical CRO Treatment Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Preclinical CRO Treatment
      • 2.3 Manufacturing Process Analysis of Preclinical CRO Treatment
      • 2.4 Industry Chain Structure of Preclinical CRO Treatment

      3 Development and Manufacturing Plants Analysis of Preclinical CRO Treatment

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Preclinical CRO Treatment Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Preclinical CRO Treatment
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Preclinical CRO Treatment Production and Capacity Analysis
      • 4.2 Preclinical CRO Treatment Revenue Analysis
      • 4.3 Preclinical CRO Treatment Price Analysis
      • 4.4 Market Concentration Degree

      5 Preclinical CRO Treatment Regional Market Analysis

      • 5.1 Preclinical CRO Treatment Production by Regions
        • 5.1.1 Global Preclinical CRO Treatment Production by Regions
        • 5.1.2 Global Preclinical CRO Treatment Revenue by Regions
      • 5.2 Preclinical CRO Treatment Consumption by Regions
      • 5.3 North America Preclinical CRO Treatment Market Analysis
        • 5.3.1 North America Preclinical CRO Treatment Production
        • 5.3.2 North America Preclinical CRO Treatment Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Preclinical CRO Treatment Import and Export
      • 5.4 Europe Preclinical CRO Treatment Market Analysis
        • 5.4.1 Europe Preclinical CRO Treatment Production
        • 5.4.2 Europe Preclinical CRO Treatment Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Preclinical CRO Treatment Import and Export
      • 5.5 China Preclinical CRO Treatment Market Analysis
        • 5.5.1 China Preclinical CRO Treatment Production
        • 5.5.2 China Preclinical CRO Treatment Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Preclinical CRO Treatment Import and Export
      • 5.6 Japan Preclinical CRO Treatment Market Analysis
        • 5.6.1 Japan Preclinical CRO Treatment Production
        • 5.6.2 Japan Preclinical CRO Treatment Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Preclinical CRO Treatment Import and Export
      • 5.7 Southeast Asia Preclinical CRO Treatment Market Analysis
        • 5.7.1 Southeast Asia Preclinical CRO Treatment Production
        • 5.7.2 Southeast Asia Preclinical CRO Treatment Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Preclinical CRO Treatment Import and Export
      • 5.8 India Preclinical CRO Treatment Market Analysis
        • 5.8.1 India Preclinical CRO Treatment Production
        • 5.8.2 India Preclinical CRO Treatment Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Preclinical CRO Treatment Import and Export

      6 Preclinical CRO Treatment Segment Market Analysis (by Type)

      • 6.1 Global Preclinical CRO Treatment Production by Type
      • 6.2 Global Preclinical CRO Treatment Revenue by Type
      • 6.3 Preclinical CRO Treatment Price by Type

      7 Preclinical CRO Treatment Segment Market Analysis (by Application)

      • 7.1 Global Preclinical CRO Treatment Consumption by Application
      • 7.2 Global Preclinical CRO Treatment Consumption Market Share by Application (2014-2019)

      8 Preclinical CRO Treatment Major Manufacturers Analysis

      • 8.1 Charles River Laboratories
        • 8.1.1 Charles River Laboratories Preclinical CRO Treatment Production Sites and Area Served
        • 8.1.2 Charles River Laboratories Product Introduction, Application and Specification
        • 8.1.3 Charles River Laboratories Preclinical CRO Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Laboratory Corporation of America
        • 8.2.1 Laboratory Corporation of America Preclinical CRO Treatment Production Sites and Area Served
        • 8.2.2 Laboratory Corporation of America Product Introduction, Application and Specification
        • 8.2.3 Laboratory Corporation of America Preclinical CRO Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Envigo
        • 8.3.1 Envigo Preclinical CRO Treatment Production Sites and Area Served
        • 8.3.2 Envigo Product Introduction, Application and Specification
        • 8.3.3 Envigo Preclinical CRO Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Eurofins Scientific
        • 8.4.1 Eurofins Scientific Preclinical CRO Treatment Production Sites and Area Served
        • 8.4.2 Eurofins Scientific Product Introduction, Application and Specification
        • 8.4.3 Eurofins Scientific Preclinical CRO Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 PRA Health Science
        • 8.5.1 PRA Health Science Preclinical CRO Treatment Production Sites and Area Served
        • 8.5.2 PRA Health Science Product Introduction, Application and Specification
        • 8.5.3 PRA Health Science Preclinical CRO Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Wuxi AppTec
        • 8.6.1 Wuxi AppTec Preclinical CRO Treatment Production Sites and Area Served
        • 8.6.2 Wuxi AppTec Product Introduction, Application and Specification
        • 8.6.3 Wuxi AppTec Preclinical CRO Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Medpace
        • 8.7.1 Medpace Preclinical CRO Treatment Production Sites and Area Served
        • 8.7.2 Medpace Product Introduction, Application and Specification
        • 8.7.3 Medpace Preclinical CRO Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Pharmaceutical Product Development
        • 8.8.1 Pharmaceutical Product Development Preclinical CRO Treatment Production Sites and Area Served
        • 8.8.2 Pharmaceutical Product Development Product Introduction, Application and Specification
        • 8.8.3 Pharmaceutical Product Development Preclinical CRO Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Paraxel
        • 8.9.1 Paraxel Preclinical CRO Treatment Production Sites and Area Served
        • 8.9.2 Paraxel Product Introduction, Application and Specification
        • 8.9.3 Paraxel Preclinical CRO Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served

      9 Development Trend of Analysis of Preclinical CRO Treatment Market

      • 9.1 Global Preclinical CRO Treatment Market Trend Analysis
        • 9.1.1 Global Preclinical CRO Treatment Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Preclinical CRO Treatment Regional Market Trend
        • 9.2.1 North America Preclinical CRO Treatment Forecast 2019-2025
        • 9.2.2 Europe Preclinical CRO Treatment Forecast 2019-2025
        • 9.2.3 China Preclinical CRO Treatment Forecast 2019-2025
        • 9.2.4 Japan Preclinical CRO Treatment Forecast 2019-2025
        • 9.2.5 Southeast Asia Preclinical CRO Treatment Forecast 2019-2025
        • 9.2.6 India Preclinical CRO Treatment Forecast 2019-2025
      • 9.3 Preclinical CRO Treatment Market Trend (Product Type)
      • 9.4 Preclinical CRO Treatment Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Preclinical CRO Treatment Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Preclinical CRO Treatment. Industry analysis & Market Report on Preclinical CRO Treatment is a syndicated market report, published as Global Preclinical CRO Treatment Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Preclinical CRO Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,705.50
        4,058.25
        5,411.00
        3,258.50
        4,887.75
        6,517.00
        534,415.00
        801,622.50
        1,068,830.00
        295,400.00
        443,100.00
        590,800.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report